A T-cell test developed by Adaptive Biotechnologies could become the first commercially available test of its kind, and it may be more effective at detecting past COVID-19 infections than antibody ...
An international research team with strong participation from DTU has developed a new biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and ...
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...
For San Diego researchers and the wider immunotherapy community, the atlas functions as a practical roadmap. It does not ...
Worth up to $850 million, the partnership provides “further validation” for Janux at a time of heightened investor scrutiny ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results